UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000012480
Receipt number R000014596
Scientific Title A phase 2 study of combination neoadjuvant chemotherapy with gemcitabine S-1 and leucovorin in patients with borderline and locally advanced pancreatic cancer
Date of disclosure of the study information 2013/12/04
Last modified on 2019/06/09 14:43:39

No. Disposal Last modified on Item of update
1 Insert 2013/12/03 23:03:25
2 Update 2017/05/31 18:29:02 Recruitment status
3 Update 2017/12/06 22:35:21 Last name of lead principal investigator
Last name of lead principal investigator
Email
Name of primary person or sponsor
Organization
Organization
Organization
4 Update 2019/06/09 14:20:41 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
5 Update 2019/06/09 14:22:07 Number of participants that the trial has enrolled
6 Update 2019/06/09 14:23:27 Recruitment status
Date of IRB
Last follow-up date
7 Update 2019/06/09 14:43:39 URL releasing protocol
Publication of results
URL related to results and publications
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures